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This article reports on a study of the mineralisation behaviour of CaCO3 deposited on electrospun poly(3-
caprolactone) (PCL) scaﬀolds preliminarily treated with low-temperature plasma. This work was aimed at
developing an approach that improves the wettability and permeability of PCL scaﬀolds in order to obtain
a superior composite coated with highly porous CaCO3, which is a prerequisite for biomedical scaﬀolds
used for drug delivery. Since PCL is a synthetic polymer that lacks functional groups, plasma processing of
PCL scaﬀolds in O2, NH3, and Ar atmospheres enables introduction of highly reactive chemical groups,
which inﬂuence the interaction between organic and inorganic phases and govern the nucleation, crystal
growth, particle morphology, and phase composition of the CaCO3 coating. Our studies showed that the
plasma treatment induced the formation of O- and N-containing polar functional groups on the scaﬀold
surface, which caused an increase in the PCL surface hydrophilicity. Mineralisation of the PCL scaﬀolds was
performed by inducing precipitation of CaCO3 particles on the surface of polymer ﬁbres from a mixture of
CaCl2- and Na2CO3-saturated solutions. The presence of highly porous vaterite and nonporous calcite
crystal phases in the obtained coating was established. Our ﬁndings conﬁrmed that preferential growth of
the vaterite phase occurred in the O2-plasma-treated PCL scaﬀold and that the coating formed on this
scaﬀold was smoother and more homogenous than those formed on the untreated PCL scaﬀold and the
Ar- and NH3-plasma-treated PCL scaﬀolds. A more detailed three-dimensional assessment of the
penetration depth of CaCO3 into the PCL scaﬀold was performed by high-resolution micro-computed
tomography. The assessment revealed that O2-plasma treatment of the PCL scaﬀold caused CaCO3 to
nucleate and precipitate much deeper inside the porous structure. From our ﬁndings, we conclude that
O2-plasma treatment is preferable for PCL scaﬀold surface modiﬁcation from the viewpoint of use of the
PCL/CaCO3 composite as a drug delivery platform for tissue engineering.Introduction
One of the most eﬀective strategies for bone regeneration is the
use of composite scaﬀolds that mimic the structure and biolog-
ical features of extracellular matrices (ECM) of bone. PorousMaterials Centre, Research School of
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4electrospun scaﬀolds oﬀer signicant advantages over various
other candidate materials, mainly because of their high surface-
to-volume ratios, high porosity, and spatial interconnectivity,
which are benecial for cell migration, drug loading, and
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View Article Onlinefor scaﬀold fabrication, such as poly(lactic acid) (PLA),1–4 poly(-
lactic-co-glycolic acid) (PLGA),1,5,6 and poly(3-caprolactone)
(PCL).1,7–11 PCL is benecial for tissue regeneration and drug
delivery applications on account of its biocompatibility, proc-
essability, degradability, and mechanical properties. However,
the surface wettability and osteoconductivity of PCL materials
require improvement given the low cell attachment and prolif-
eration on untreated PCL scaﬀolds.7,8 Several surface modica-
tion techniques such as chemical treatment, lm deposition,
blending, ion beam radiation, and plasma treatment have been
developed to overcome these shortcomings.2,3,7,9,12 The most
promising techniques are plasma treatment and biomineralisa-
tion of polymer scaﬀolds.12–14 Plasma treatment is an eﬀective
surface modication method for improving the surface and
biological properties of PCL materials without altering the
properties of the bulk. Plasma treatment is a non-solvent process
that involves the use of a smaller amount of chemical reagents
and facilitates changes in the chemical composition, wettability,
surface energy, refractive index, hardness, chemical inertness,
and biocompatibility of a PCL material.14 The weak chemical
bonds of PCL are replaced with highly reactive amine, carboxy,
hydroxy, and aldehyde groups by the use of glow discharges of
non-deposition gases such as NH3, O2, and Ar.15–17 A previous
study reported that these chemical groups could act as binding
sites for cell adhesion and protein adsorption.13 Because of the
presence of functional groups, plasma-modied polymer
surfaces have applicability to biomolecular immobilisation.18,19
Introduction of inorganic particles into the polymer scaﬀold and
deposition of a thin lm on the scaﬀold surface to achieve
superior features for bone tissue substitution are highly prom-
ising approaches for biomineralisation of the scaﬀold surface or
bulk. Various inorganic species have been used for this purpose,
such as hydroxyapatite (HAp), bioactive glass, CaCO3, and
TiO2.20,21 Among these species, CaCO3 is advantageous because of
its biocompatibility, simple synthesis method, and straightfor-
ward decomposition conditions. CaCO3 has three anhydrous
crystallographic polymorphs: vaterite, aragonite, and calcite.
Many approaches have been developed to control the
morphology and polymorphs of CaCO3.22–27 Specically, vaterite
is the least stable, and thus the most challenging, phase of
CaCO3, which possesses an orthorhombic or hexagonal crystal
structure. Savelyeva et al. studied the deposition of porous CaCO3
coatings on electrospun PCL bres;7 they obtained various
structures and phase compositions of the CaCO3 coatings by
varying the growth conditions (incubation time and ultrasonic
treatment). The vaterite-calcite transformation in CaCO3 was
induced by an increase in the number of consecutive treatments,
which could be explained by the Ostwald ripening process. Their
study suggested that as the size of the vaterite crystallites
increased beyond a critical value, the process of recrystallisation
of vaterite to calcite occurred. However, Andreassen showed that
spherical and polycrystalline particles of vaterite precipitated
from solution and grew by a spherulitic growth mechanism, and
not by aggregation of nanosized precursor crystals.22 This work
suggested that the transformation of vaterite to calcite was not
a solid-state transformation but a surface-controlled process.22
This implies that the dissolution of vaterite and the nucleation ofThis journal is © The Royal Society of Chemistry 2018calcite are two parallel processes. Thus, three stages of CaCO3
formation are diﬀerentiated: occurrence and disappearance of an
unstable amorphous CaCO3 phase, crystallisation and dissolu-
tion of the metastable vaterite phase, and precipitation of the
thermodynamically stable calcite phase.22,25–27 Vaterite CaCO3
usually occurs in the form of highly porous spherical particles,
which are benecial from the viewpoint of bonding of the scaf-
fold with bone tissue and for the use of the scaﬀold as a drug
delivery system. Saveleva et al. recently tested a PCL/CaCO3
scaﬀold loaded with tannic acid as a model substance in vivo and
demonstrated benecial eﬀects of the implanted scaﬀold on the
stabilisation of blood vessels in rats by the release of loaded
drugs, which, in turn, was induced by the recrystallisation of
vaterite to calcite.28 It was also shown that the introduction of
vaterite particles as a ller or coating onto polymer scaﬀolds
induced the biomimetic precipitation of HAp from simulated
body uid.21,29
A number of studies demonstrated that the nucleation and
growth processes of CaCO3 crystals are aﬀected by the micro-
environment.30,31 As described above, plasma treatment can
change the surface properties of PCL bres. It is well estab-
lished that plasma treatment causes activation of the surface
layer of the polymer scaﬀold and the formation of some
dangling bonds or free radicals,15–17 which may attract oxygen or
moisture when the plasma-treated polymer scaﬀolds are
exposed to air.32 To the best of our knowledge, no data are yet
available on the formation of a CaCO3 coating on plasma-
treated PCL and the correlation of CaCO3 lm properties with
the gas atmosphere of the plasma discharge. In the present
study, therefore, we demonstrate that PCL/CaCO3 scaﬀolds with
modied surface properties can be developed by combining
plasma treatment of PCL with wet precipitation methods. The
eﬀect of plasma treatment on the CaCO3 mineralisation process
is investigated by several analytical techniques, including X-ray
diﬀraction (XRD), scanning electron microscopy (SEM), and X-
ray photoelectron spectroscopy (XPS), and high-resolution
micro-computed tomography (mCT).Experimental section
Electrospinning of PCL scaﬀolds
Micro-brous scaﬀolds were produced using the electro-
spinning instrument at the National Research Tomsk Poly-
technic University, Russia.33 PCL (Mn ¼ 80 000 g mol1, Sigma-
Aldrich, USA) was dissolved in chloroform (CHCl3) at a concen-
tration of 9% (w/v). The solutions were loaded into a 10 mL
plastic syringe with a stainless-steel needle (diameter: 0.58
mm). The ow rate of the solution was 3.6 mL h1. The needle
was connected to a high-voltage power supply, which generated
a voltage of 8 kV. Randomly oriented bres were deposited on
a grounded drum collector (rotation speed: 600 rpm) located at
a distance of 8 cm from the needle tip.Plasma treatment of PCL scaﬀolds
Plasma treatment of the PCL scaﬀolds was performed in
a dielectric barrier discharge plasma system in a direct modeRSC Adv., 2018, 8, 39106–39114 | 39107
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View Article Online(Fraunhofer Institute for Interfacial Engineering and Biotech-
nology, Germany) by use of an RF power generator (13.56 MHz).
Diﬀerent working gases were used for processing the PCL
scaﬀolds with a constant gas ow of 30 cm3 min1: 99.99% O2,
99.99% Ar, and 99.99% NH3. All plasma treatments were per-
formed for 120 s under a pressure of 30 Pa with applied
discharge powers of 30 W and 50 W for Ar plasma and O2 and
NH3 plasmas, respectively. Electrospun bre mats 2  2 cm2 in
size were treated with plasma in each of the three gas atmo-
spheres and then cut into 8 samples 0.5  1 cm2 in size each for
further investigation and mineralisation.
Enrichment of PCL scaﬀolds with CaCO3
The procedure for the formation of CaCO3 on the PCL scaﬀolds
was similar to that described elsewhere.7 Briey, CaCO3 parti-
cles were crystallised on the surface of polymer bres from
a mixture of 1 M-CaCl2-saturated and 1 M-Na2CO3-saturated
solutions. The CaCl2 and Na2CO3 solutions were prepared using
calcium chloride dihydrate (CaCl2$2H2O; Sigma-Aldrich
Chemie, Germany) and sodium carbonate (Na2CO3; Sigma-
Aldrich Chemie, Germany), respectively. First, the PCL scaf-
fold samples (0.5  1 cm2) were treated with 1 mL of CaCl2
solution in an ultrasonic bath until complete wetting was ach-
ieved. Complete wetting of scaﬀolds that were pretreated with
the O2 plasma was achieved immediately, whereas that of the
other scaﬀolds was achieved in about 10 min. Subsequently,
1 mL of the Na2CO3 solution was added to the system upon
ultrasonication, aer which the system was subjected to ultra-
sound for 30 s. Finally, the samples immersed in the solution
were kept out for 60 s to complete the crystallisation process
and washed twice with deionised (DI) water. The mineralisation
of the PCL scaﬀolds was performed twice and completed with
drying of the samples at 40–45 C for 30–40 min.
Characterisation of scaﬀolds
Scanning electron microscopy. The morphology of the PCL/
CaCO3 scaﬀolds was studied using a scanning electron micro-
scope (MIRA II LMU, Tescan, Czech Republic) at an operating
voltage of 30 kV.
Wettability. Before the mineralisation process, the wetta-
bility of all the scaﬀolds was measured. Three drops of Milli-Q
water (2 mL) were released at various positions on the surface
of each scaﬀold. The shapes of the drops were recorded using
CoolingTech Microscope, and their contact angles were calcu-
lated with ImageJ soware.
X-ray photoelectron spectroscopy. XPS of the plasma-treated
samples was performed using a PHI VersaProbe II XPS system
with a monochromatic AlKa beam (hn ¼ 1486.6 eV) operating at
51.4 W. All measurements were performed in a vacuum of at
least 106 Pa, and the photoelectrons were detected with
a hemispherical analyser positioned at an angle of 45 with
respect to the normal of the sample surface. Survey scans and
high-resolution C1s and N1s spectra were recorded with pass
energies of 187.8 eV and 23.5 eV, respectively. CasaXPS soware
was used to t the curves of the high-resolution peaks. A linear-
type background was subtracted and Gaussian–Lorentzian peak39108 | RSC Adv., 2018, 8, 39106–39114components were tted to the high-resolution spectra. The
hydrocarbon component of the C1s spectrum (285.0 eV) was
used to calibrate the energy scale.
X-ray diﬀraction. XRD was used to determine the crystallo-
graphic structures of the CaCO3 particles in the scaﬀolds. XRD
analysis was performed using a Shimadzu XRD-6000 (Japan) X-
ray diﬀractometer by using CuKa radiation (l ¼ 0.154 nm) in
a 2q range of 10–70 with a step size of 0.03 and a scanning rate
of 2 in 2qmin1. The diﬀractometer was operated at 40 kV and
30 mA.
Synchrotron mCT imaging and data analysis. For the mCT
analysis, samples of the untreated PCL/CaCO3 scaﬀold and the
PCL/CaCO3 scaﬀold subjected to O2-plasma treatment were
chosen. A mCT system installed at a bending magnet source at
the Institute for Photon Science and Synchrotron Radiation,
Karlsruhe Institute of Technology (KIT, Karlsruhe, Germany),
was used for three-dimensional (3D) non-destructive imaging.34
The white beam (broad energy spectrum: 1.5–40 keV) was used
for the experiment. The imaging setup consisted of a detector
composed of a 200 mm-thick Lu3Al5O12 scintillator; an Optique
Peter white beam microscope with a magnication of 10; and
a pco.Dimax CMOS camera having 2016  2016 pixels with
a physical pixel size of 11 mm, which corresponded to an
eﬀective pixel size of 1.1 mm. For each tomography measure-
ment, 6000 projections—each with an exposure time of 25 ms—
were recorded. The distance between the sample and the
detector (propagation distance) was set to 25 mm. The beam
uctuations, noise from the detector, cracks, and imperfections
of the scintillator were ltered out from the projections by the
use of reference images without a sample. Tomographic
reconstructions were performed using the ltered back-
projection algorithm implemented in the UFO framework
developed at KIT.35
The reconstructed datasets were ltered using a median
lter with a radius of 1.8 mm in a slice-by-slice manner. Then,
each slice was segmented using entropy-based and Otsu
thresholding algorithms implemented with the NumPy and
scikit-image packages of the Python programming language.36
The segmentation process generates binary datasets in which
only the material has non-zero values. Then, the segmented
slices were analysed using the Quanma package,37 mainly by
means of the connected component algorithm provided by the
scikit-image package.38 The size and orientation of the bres,
the porosity of the PCL/CaCO3 scaﬀold, and the ratio of the
CaCO3 volume to the total volume of the PCL scaﬀold were
calculated for each sample. The 3D visualisation was performed
using the Amira 5.4.1 soware (FEI Visualization Sciences
Group). The Matplotlib package was used for plotting 2D
charts.39
Results and discussion
Previous studies demonstrated that plasma treatment of PCL
samples induced formation of O-containing and N-containing
polar functional groups on the surface, which caused an
increase in the surface energy and thus enhanced the hydro-
philic properties of the samples.12–19 This is because polymerThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinemineralisation reactions between organic and inorganic phases
are signicant and can control the crystal growth, particle
morphology, and spatial arrangement of CaCO3 agglomerates.
Liu et al. and Ma et al. studied the eﬀect of graing of diﬀerent
functional groups on substrates on the crystallisation process of
CaCO3.23,24 As changes in the functional groups and wettability
of the surface are expected to aﬀect the mineralisation behav-
iour of CaCO3, we used XPS and contact angle measurements to
characterise the surface of PCL samples treated with plasma in
diﬀerent atmospheres prior to enrichment with CaCO3.Surface properties of electrospun PCL scaﬀolds before and
aer plasma treatment
The wettability of PCL scaﬀold surfaces before and aer plasma
treatment in O2, NH3, and Ar atmospheres was evaluated by
measuring the contact angle of DI water. The change in the
surface hydrophobicity of the plasma-treated samples is shown
in Fig. 1.
The untreated PCL scaﬀold was hydrophobic, with a water
contact angle of 123  10. Aer plasma treatment, depending
on the gas atmosphere used in the plasma treatment, the PCL
surface became more hydrophilic. The DI water contact angles
for the PCL scaﬀolds treated in the NH3- and Ar-plasma atmo-
spheres decreased from 123  10 to 102  5 and to 69 
10, respectively. The lowest contact angle was observed for the
PCL scaﬀold treated with O2 plasma (30  6). The decrease in
the contact angle of a water drop is considered to be referred
mainly to the enhancement of the total surface energy of the
ber substrate as well as the generation of new binding states by
the plasma treatment.40,41 The obtained data indicate that the
plasma treatment with oxygen considerably increases the
formation of polar species on the PCL surface. These ndings
are consistent with previous studies.32,42 These results obviously
indicate that the direct plasma treatment provides an eﬀective
improvement of surface hydrophilicity that is essential for deep
penetration of reagents for deposition of CaCO3.Fig. 1 Contact angle of PCL scaﬀolds before and after plasma treat-
ment under diﬀerent atmospheres.
This journal is © The Royal Society of Chemistry 2018All the untreated and plasma-treated PCL scaﬀolds were
further analysed by XPS, as shown in Fig. 2a. From the XPS
survey spectra, we calculated the atomic ratios (at%) of C, O,
and N on the surface of the PCL scaﬀolds (Table 1). The surface
of the untreated PCL scaﬀold sample contained 81.5 at% C and
18.5 at% O. This C content was slightly higher than that ex-
pected for PCL (C6H10O2), because of the presence of adventi-
tious hydrocarbon contaminants, which is inevitable in
a laboratory environment.
Aer Ar- and O2-plasma treatments, the O content of the PCL
surfaces increased to 23.0 at% and 24.6 at%, respectively.
However, aer the NH3-plasma treatment, the O content of the
PCL surface decreased slightly to 17.5 at% (from 18.5 at%, i.e.
the O content of the untreated PCL scaﬀold). This result can be
explained by the dissociation of NH3 in the plasma into
hydrogen atoms and its reaction with the O on the polymer
surface.43 Aer NH3-plasma treatment, the N1s peak was
observed in the XPS survey spectra, which indicates the incor-
poration of 1.25 at% N into the polymer surface. Higher-
resolution spectra of the C1s and N1s regions are shown in
Fig. 2b. The C1s line can be resolved into three peaks, which
reect the local environments of the carbon atoms. For
instance, the peak at 285 eV corresponds to the hydrocarbon
environment (the C1 group), that at 285.9 eV corresponds to the
carbon monoxide environment (the C2 group), and that at
289.1 eV corresponds to other carbon oxide environments (the
C3 group). The N1s curve of the PCL sample treated with NH3
plasma was tted using three peaks, two of which could be
assigned to the amine (N1, 398.9 eV) and imide (N2, 400.5 eV)
groups.32,44 The third peak, located at a higher binding energy
(403.8 eV), was ascribed to oxidised nitrogen species (N3).
While the XPS spectra of all the studied PCL scaﬀolds were
similar in terms of the overall content, they diﬀered in terms of
the proportions of carbon environments. Aer O2-plasma
treatment, there was an evident increase in the amount of C3
groups, which was attributed to the oxidation of the PCL
surface. A previous study showed that these oxygen-containing
groups improve surface hydrophilicity.45 The XPS spectra of
the samples treated with Ar plasma also showed higher
amounts of the C2 and C3 groups in comparison to the
untreated sample. There are two possible explanations for this
observation. Either the plasma chamber with Ar gas contains
a very small amount of oxygen or highly active groups are
formed in the Ar plasma, which subsequently react with oxygen
when exposed to air.46Inuence of plasma treatment on deposited CaCO3-based
coating
Calcium carbonate enriched PCL scaﬀolds without and aer
plasma treatment are shown in Fig. 3. There are visible diﬀer-
ences in the particle dispersion and CaCO3 coating homoge-
neity on the PCL surface between the plasma-treated and
untreated scaﬀolds. For the untreated PCL scaﬀold and the
sample exposed under Ar atmosphere many CaCO3 agglomer-
ates protrude out (the areas enclosed by a circle in Fig. 3). For
the coating deposited on the O2-plasma treated PCL a ratherRSC Adv., 2018, 8, 39106–39114 | 39109
Fig. 2 XPS spectra of PCL scaﬀolds before and after plasma treatment: survey spectra (a) and high-resolution spectra (b).
Table 1 Surface elemental compositions derived from XPS survey
spectra
Processing
condition
Atomic percentage
C/O ratioC1s O1s N1s
PCL 81.5 18.5 4.4
PCL(O2) 75.4 24.6 3.1
PCL(NH3) 81.1 17.5 1.25 4.6
PCL(Ar) 77.1 23.0 3.4
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View Article Onlinesmooth and homogeneous surface is observed. The CaCO3
coating consists of agglomerates of spherical porous CaCO3
microparticles referred to vaterite (white arrows in Fig. 3). A
clear diﬀerence in the particles morphology of the CaCO339110 | RSC Adv., 2018, 8, 39106–39114coating deposited on the PCL scaﬀold treated in the NH3-
plasma atmosphere compared with other samples is displayed.
It seems that the coating on this sample consists of cubic
particles (black arrows in Fig. 3), which indicate the presence of
the calcite phase.
The XRD spectra of the untreated and plasma-treated PCL
scaﬀolds aer mineralisation are shown in Fig. 4. The deposited
coating is composed of the vaterite and calcite phases. The
diﬀractograms show three diﬀraction peaks assigned to the
(112), (114), and (300) planes of the vaterite phase (ICDD card
no. 86-0174) and one peak assigned to the (104) plane of the
calcite phase resolved at 29 (ICDD card no. 86-0174). The
presence of calcite is established in all the studied samples. The
observed XRD peaks are quite broad, which leads to the
conclusion that the CaCO3 coatings deposited on the surface ofThis journal is © The Royal Society of Chemistry 2018
Fig. 3 SEM images of PCL/CaCO3 scaﬀolds before and after plasma
treatment at diﬀerent magniﬁcations.
Fig. 4 XRD spectra of PCL/CaCO3 scaﬀolds before and after plasma
treatment. The ratio of the integrated intensity of the calcite phase (Ic)
to the total integrated intensity (IS) represents the relative proportion
of the calcite phase in the deposited coatings.
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View Article Onlinethe PCL scaﬀolds are nanocrystalline. The integrated intensities
of vaterite and calcite were measured from the corresponding
reections of the X-ray diﬀractograms by means of IGOR Pro
soware. The ratio of the integrated intensity of the calcite
phase (Ic) to the total integrated intensity (IS) represents the
relative proportions of these two phases in the deposited coat-
ings. The lower the Ic/IS ratio, the higher is the number of
vaterite crystals in the coating. The results showed that the
vaterite phase grewmore preferentially in the O2-plasma-treated
PCL scaﬀold sample than in the untreated and Ar- and NH3-
plasma-treated PCL scaﬀold samples.
The diﬀerences in the CaCO3 coating morphology and phase
composition observed in our study are attributed to the
diﬀerent eﬀects of the three plasma treatments of the PCLThis journal is © The Royal Society of Chemistry 2018scaﬀolds. We assume that the O2-plasma treatment leads to the
formation of a large number of active growth sites for the
nucleation of vaterite particles, which results in a more
homogenous and smoother coating morphology than that
achieved with the Ar- and NH3-plasma treatments. In the NH3
atmosphere, the PCL surface becomes saturated with amino
groups, which induce crystallisation of CaCO3 into calcite. Ma
et al. reported that the interaction between –NH3
+ groups in
a chitin lm and CO3
2 aﬀects the nucleation of CaCO3 and
leads to the irregular formation of calcite.24
The homogenous CaCO3 coating deposited on the O2-
plasma-treated PCL scaﬀold sample showed the best results in
terms of wettability and vaterite phase content. Thus, this
sample has the highest potential for bone engineering. There-
fore, only the PCL/CaCO3 scaﬀolds treated with O2 plasma were
used for further analysis.Synchrotron mCT imaging of PCL/CaCO3 scaﬀolds aer O2-
plasma treatment
We used synchrotron mCT for a complementary 3D analysis of the
internal characteristics of the scaﬀolds and the inuence of O2
plasma on the calcication process of the bre structure. Fig. 5a
and b shows 3D renderings of the reconstructed volumes from
the mCT data. The PCL bres and CaCO3 particles are rendered in
blue and red, respectively. To obtain a more representative view,
regions of interest (ROI) with a 3D area of 550  440  880 mm3
and magnied regions with a 3D area of 100  100  100 mm3
were extracted. Reconstructed volumes enable visualisation of
the CaCO3 present within the scaﬀold at diﬀerent depths (Fig. 5c
and d, 3D rendering of CaCO3 only). Spatial arrangement of the
CaCO3 agglomerates in the 3D reconstructions corresponds to
the plasma propagation direction. The O2-plasma-treated scaf-
fold shows larger agglomerates and deeper penetration of CaCO3
than does the untreated PCL scaﬀold (see Fig. 5d).
From the high-resolution 3D volume, we calculated the PCL
bre diameter, ratio of the CaCO3 volume to the total sample
volume, and porosity for both the PCL/CaCO3 samples (ESI
Fig. S1†). For both the samples, the bre diameters are found toRSC Adv., 2018, 8, 39106–39114 | 39111
Fig. 5 X-ray-mCT-based visualisation of full and cropped volumes of untreated PCL/CaCO3 scaﬀolds (a and c) and PCL/CaCO3 scaﬀolds after
O2-plasma treatment (b and d) and CaCO3 distribution within the volume of 3D scaﬀolds (c and d). The polymer and inorganic phases are shown
in blue and red-yellow colours, respectively. The colour bar represents the X-ray linear attenuation coeﬃcient in mm1.
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View Article Onlinerange from 1 mm to 15 mm, with very similar distributions. Pie
charts show that the predominant bre diameter in both the
samples is in the range of 1–5 mm. The O2-plasma-treated
scaﬀold sample shows a higher ratio of the CaCO3 volume to
the total volume (0.82%  0.11%) than the untreated scaﬀold
sample (0.63%  0.11%).
Because of the higher volume of CaCO3 agglomerates in the
O2-plasma-treated PCL/CaCO3 scaﬀold, the porosity of this
scaﬀold is lower (82%) than that of the untreated scaﬀold
(88%). Such deep penetration of CaCO3 into the O2-plasma-
treated PCL scaﬀold can be explained by its higher surface
wettability. Moreover, values of the X-ray linear attenuation
coeﬃcient reveal that the mineral density of the scaﬀold surface
pretreated with O2 plasma is higher than that of the untreated
scaﬀold. The highly reactive chemical groups on the surface of
the O2-plasma-treated PCL scaﬀold potentially act as nucleation
sites for CaCO3 and control the formation of crystals.
Plasma treatment is a basic approach to modify the elec-
trospun scaﬀold surface prior to biomineralization. There are
a number of reports on using plasma pre-treated PCL bers as
an active substrate for biomimetic growth of the calcium
phosphates.47–49 For instance, Yang et al. achieved a homoge-
neous coating of CaP coating onto polymer scaﬀolds aer Ar-
plasma treatment and a long period (2–6 h and 7 days) of
immersion in simulated body uid (SBF).49 Lebourg et al. re-
ported the deposition of CaP layers grown on PCL treated with39112 | RSC Adv., 2018, 8, 39106–39114air plasma and subsequently immersed in SBF for 14 days.48 An
improvement in the wettability of the electrospun PCL scaﬀolds
and osteoblast-like cell adhesion was observed. Despite prom-
ising results, which were obtained, suﬃcient period of time was
required for the surface-modied samples to promote the
nucleation of the CaP with the desired phase composition.
Moreover, during the biomimetic coating deposition, the pore
size of the polymer scaﬀolds was reduced signicantly. The
latter fact may be a limiting factor since the porous structure is
essential for cell migration, it is important to keep this structure
to the most extent. The processing of the PCL scaﬀolds applied
in this work does not have the mentioned disadvantages. The
deposition of the dense CaCO3 porous layer took 3 min in total
and the structure of the ber web remained unchanged.
Nevertheless, the main advantage of the vaterite deposits on the
PCL scaﬀold surface is that they can serve as a drug delivery
vehicle. Despite excellent osteoconductivity and ease of appli-
cability, use of CaPs as a drug delivery coating is limited. It is
known that the development of a coating with high total
porosity does not ensure drug molecules penetration and
elution, unless there is an adequate pore size distribution.50 As
shown in ref. 47–49, the biomimetic CaP coating is formed by
a mesh of interlocking of ack-like crystals, which allows to
create an open microporosity. This structure is suitable for the
short time drug administration, because the incorporated drug
release is diﬀusion-controlled. However, a sustained drugThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinedelivery has attracted more interest. There is still a lot to be
done in terms of adjusting the coating features to diﬀerent
therapeutical needs and obtaining predictable drug delivery
systems. But, since the vaterite particles are the least stable
polymorph form of calcium carbonate, they tend to transform
into calcite in aqueous environment following by the dissolu-
tion and crystallization.51 The dissolution-precipitation process
of the CaCO3 particles has been shown to allow controlling the
drug release time, which makes CaCO3 the best candidate for
polymer scaﬀold mineralization.28
Conclusions
In summary, we investigated the dependence of the minerali-
sation behaviour of CaCO3 deposited on a plasma-pretreated
PCL scaﬀold surface on the working gas atmosphere. We
found that the type and number of active groups on the surface
of the plasma-treated PCL scaﬀolds aﬀect the subsequent
nucleation and growth of CaCO3 crystals. The obtained results
demonstrate that among the gas atmospheres used in this study
(O2, NH3, and Ar), O2 plasma is the most favourable for
promoting a positive inuence of biomaterials on CaCO3
formation. Preliminary exposure of the surface of the PCL
scaﬀold to O2 plasma promotes the formation of a homoge-
neous and smooth coating that consists mainly of CaCO3 in
a highly porous vaterite crystalline phase. Because of its unique
structure and high specic surface area, the vaterite coating has
potential for use in various biomedical applications, especially
for drug delivery. Functional groups formed on the polymer
surface by the O2-plasma treatment enhance the surface
hydrophilicity and permeability, thus inducing deeper pene-
tration of CaCO3 into the sample surface, as revealed by mCT.
Thus, O2-plasma treatment of PCL scaﬀolds results in a higher
mineralisation eﬃciency, which is required to ensure their high
drug-loading capacity; this high capacity is, in turn, necessary
for their use as implantable drug delivery systems in ortho-
paedic devices. In our future work, we intend to investigate
whether the properties of the PCL/CaCO3 composite can be
controlled by altering the process parameters of the O2-plasma
treatment and the crystallisation conditions of CaCO3. The
extent to which the biological performance of the PCL/CaCO3
scaﬀolds—particularly in terms of their eﬀects on the loading
capacity and release kinetics of diﬀerent drugs—can be
improved by O2-plasma treatment, remains to be investigated.
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